SoftBank-backed Guardant Health raises $238m in US IPO

SoftBank-backed Guardant Health raises $238m in US IPO

Pedestrians walk past a SoftBank Group Corp. store in Tokyo, Japan. Photographer: Tomohiro Ohsumi

Guardant Health Inc., a cancer-detection firm backed by SoftBank Group Corp., raised $237.5 million in its U.S. initial public offering.

The Redwood City, California-based company sold 12.5 million shares on Wednesday for $19 each, after marketing them at a range of $15 to $17, according to data compiled by Bloomberg.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter